Company Long-Term Loans and Borrowings: pasitheaclinics.com (KTTA)
The market valuation dynamics help analyze the resilience of Pasithea Therapeutics (KTTA), which develops advanced drugs for neuroinflammation and depression, where the protection of capital expenditures through grants ensures an inflow of free cash flow. Pasithea Therapeutics (KTTA) is also developing a network of specialized clinics, although R&D costs limit profit predictability, which currently stands at 0.00. The production cycle relies on sterile contract lines and high-precision equipment calibration.
Summary analytical data breakdowns for Pasithea Therapeutics Corp. (KTTA)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Total Debt to Capital Pasithea Therapeutics|KTTA - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Pasithea Therapeutics Corp|KTTA - Company Aggregate Debts|Debts to Net Assets Pasithea Therapeutics|KTTA - Company Long-Term Liabilities|Amount of Current Liabilities Pasithea Therapeutics|Intermediate Coverage Ratio pasitheaclinics.com
- earnings and market multiples details:
Summary company analytics:KTTA Pasithea Therapeutics
Debt load control is critical for Pasithea Therapeutics (KTTA), which develops costly treatments for resistant disorders. This metric aggregates all liabilities with a maturity of over one year for each date. Monitoring the organization's long-term financial debt allows for the identification of share devaluation risks in the event of unjustified borrowing. An increase in loans without the expansion of the clinic network signals a value trap. The stability of this indicator confirms the resilience of the business model.
Competitor analysis for Pasithea Therapeutics
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|vikingtherapeutics.com - Long-Term Liabilities|Company Long-Term Debts SUPN|Company Long-Term Debts Catalyst Pharma (CPRX)|Company Long-Term Debt Denali Therapeutics Inc DNLI|Long-Term Debt Volume Harmony Corp (HRMY)|Biohaven Ltd. - Company Long-Term Debts|Long-Term Debt Volume amylyx.com AMLX|TRVI (Trevi Therapeutics, Inc.) - Company Long-Term Liabilities|PRAX: Amount of Long-Term Liabilities|AVXL (Anavex Corp) - Company Long-Term Debts|CBLL: Company Long-Term Loans and Borrowings|Company Long-Term Debts PRTA|ALEC - Long-Term Debt|Company Long-Term Debts ANNX (Annexon)|Company Long-Term Debts Omeros Corp OMER|NGNE: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR (Voyager Therapeutics) - Company Long-Term Liabilities|NMRA: Amount of Long-Term Liabilities|SCLX (Scilex) - Company Long-Term Debts|TVGN: Company Long-Term Loans and Borrowings|Company Long-Term Debts ACOG|CGTX - Long-Term Debt|Company Long-Term Debt Inhibikase Therapeutics IKT|Company Long-Term Loans and Borrowings SAVA|Assertio Therapeutics - Company Long-Term Debts|COYA - Company Long-Term Debts|vistagen.com (VTGN) - Company Long-Term Debt|Long-Term Liabilities OVID (Ovid Therapeutics)|ABOS (Acumen Pharmaceuticals) - Company Long-Term Debts|Long-Term Debt cervomed.com CRVO|Company Long-Term Liabilities ATHE (Alterity Therapeutics)|Company Long-Term Debts clene.com (CLNN)|PepGen - Company Long-Term Liabilities|Amount of Long-Term Liabilities JUNS (jupiterneurosciences.com)|Relmada Therapeutics - Company Long-Term Debts|Long-Term Debt Volume annovisbio.com ANVS|GRCE: Company Long-Term Debts|Company Long-Term Liabilities Firefly Neuroscience, Inc.|Company Long-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. (NRSN) - Long-Term Debt Volume|Company Long-Term Debt Reviva Pharmaceuticals (RVPH)|Company Long-Term Debts metaviatx.com (MTVA)|NeurAxis - Company Long-Term Liabilities|Amount of Long-Term Liabilities HSDT (Helius Medical Technologies, Inc.)|PASG: Company Long-Term Liabilities|Neuphoria Therapeutics Inc. - Amount of Long-Term Liabilities|NERV: Company Long-Term Debts|athira.com (ATHA) - Company Long-Term Debts|Company Long-Term Debt Addex Therapeutics Ltd|Company Long-Term Indebtedness ALZN (Alzamend)|Company Long-Term Debts CYCN|PTIX - Long-Term Debt|Cortigent - Company Long-Term Liabilities|Company Long-Term Debts avenuetx.com ATXI|BCLI - Company Long-Term Debt|Company Long-Term Loans and Borrowings CARA (Cara Therapeutics Inc.)|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Long-Term Debt Eliem Therapeutics Inc. (ELYM)|Company Long-Term Debt Intra-Cellular Therapies Inc.|longboardpharma.com - Long-Term Liabilities|Company Long-Term Debts MRNS|Company Long-Term Debts NKGen Biotech Inc (NKGN)|Company Long-Term Debt NeuroBo NRBO|Long-Term Debt Volume Sage Therapeutics Inc (SAGE)|Synaptogenix, Inc. - Company Long-Term Debts|Long-Term Debt Volume trevena.com TRVN|VIGL (vigilneuro.com) - Company Long-Term Liabilities|WENA: Amount of Long-Term Liabilities|CERE (Cerevel) - Company Long-Term Debts